CBD and Zinc in Colorectal Cancer Cells: Laboratory Synergy Is Not a Patient Treatment

forensic toxicology working group members October 28, 2026 Forensic Toxicology

CBD and zinc-related manipulations enhanced cytotoxic effects in cultured colorectal cancer cells. These findings identify a laboratory mechanism to investigate; they do not establish that taking CBD with zinc treats colorectal cancer in people.

What the investigators manipulated

The study used human-derived LoVo and SW480 colorectal cancer cell lines. Researchers measured cell viability, examined gene expression and tested metallothionein-related interventions. CBD concentrations were selected using laboratory cytotoxicity assays.

Human-derived cells are still an in-vitro model. They are not a clinical trial, and their exposure does not reproduce absorption, metabolism, tissue delivery or toxicity in a whole person.

Gene expression and intervention supplied different evidence

CBD increased expression of several metallothionein-family genes. Additional experiments examined effects of gene transfection and zinc-ion treatment in combination with CBD. The reported enhanced effects go beyond a purely observational gene-expression association.

Nevertheless, expression is not interchangeable with protein activity, and a reduction in a viability-assay signal must be interpreted with the accompanying cell-death assays. The investigators used several methods, including an MTT assay and apoptosis-related analysis, rather than measuring patient tumor shrinkage.

What would be needed clinically

A useful clinical intervention would need an achievable exposure, selectivity for tumor over healthy tissue, acceptable toxicity and demonstrated outcomes. A concentration effective in culture does not establish that a tolerable oral dose produces the same exposure at a tumor.

The paper also compared cannabinoids rather than finding that every cannabis constituent produced identical metallothionein effects. For evaluation of cancer-related product claims, identify the compound, cell model, endpoint and experimental manipulation before accepting a broad statement about cannabis efficacy.